z-logo
open-access-imgOpen Access
Mild-to-moderate hyperhomocyst(e)inemia and risk of stroke. Result of a meta-analysis.
Author(s) -
Peter J. Kelly,
Jonathan Rosand,
Androniki Plomaritoglou,
Yuchiao Chang,
J. Philip Kistler,
Karen L. Furie
Publication year - 2001
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/str.32.suppl_1.366
Subject(s) - medicine , stroke (engine) , odds ratio , risk factor , epidemiology , homocysteine , homocystinuria , methylenetetrahydrofolate reductase , relative risk , meta analysis , cardiology , confidence interval , methionine , mechanical engineering , biochemistry , chemistry , amino acid , genotype , engineering , gene
P148 Background: Severe hyperhomocyst(e)inemia is associated with premature atherothrombosis and stroke in children with homocystinuria. Epidemiological studies indicate that mild-to-moderate hyperhomocyst(e)inemia is an independent risk factor for coronary artery disease. However, data are conflicting concerning the risk of stroke associated with mild-to-moderate hyperhomocyst(e)inemia. Aim: To describe and quantify the risk of stroke associated with elevated plasma homocyst(e)ine by meta-analysis.Methods: Relevant articles were obtained by search of Medline, Science Citation Index, and abstracts of conference proceedings. Search terms were Homocysteine, stroke, genetics and MTHFR. Exposure was defined as hyper-homocyst(e)inemia, relative to control values in each study population. Outcome was defined as ischemic stroke confirmed by neuroimaging (NI), and stroke without NI. Inclusion criteria: (1) Case-control (C-C) studies with reported odds ratios (OR) (2) Cohort (COH) studies with reported risk ratios (RR). Exclusion criteria: (1) Studies without clearly-defined OR/RR (reviews, C-C without OR, cross-sectional studies, case series, case reports) (2) Studies which defined outcome as carotid atherosclerosis or intima-media thickening. Statistical analyses for between-study heterogeneity and pooled risk estimates were performed using Stata software©.Results: Of 35 studies analyzed in detail, 15 (2 COH, 13 C-C) met inclusion criteria. Of 13 C-C studies (1306 cases, 6793 controls), the adjusted OR ranged 0.99–4.7, two had adjusted OR <=1 and 5 had a lower confidence limit <1. A random-effects model estimated a weighted pooled adjusted OR of 1.69 (95% CI 1.3, 2.2) from the 13 C-C studies. Within the 2 cohort studies (2825 subjects), the average adjusted RR was 1.86 (upper vs lower quantiles) (95% CI 1.14, 3.03).Conclusions: On average, mild-moderate hyperhomocyst(e)inemia is independently associated with a 69% increase in the odds and 86% increase in the risk of stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom